Barely Significant
← all excerpts

Restoring colistin sensitivity in colistin-resistant E. coli: Combinatorial use of MarR inhibitor with efflux pump inhibitor.

Sci Rep · 2019 · PMC6934491 · PMID 31882661

Europe PMCDOI
1
hedged sentence
0.0100
closest p · 0.2× alpha
0.0100
boldest claim

The sentences

highly significantP < 0.01actually significant
The reduction in bioburden due to triad treatment (colistin + salicylate + BC1) was highly significant (P < 0.01) relative to either untreated control/ colistin treatment/ Col + Sal + CCCP treatment as determined by the student’s t-test (Fig. 6 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.